Glutamine

The main fuel for your gut lining. It helps a specific kind of IBS, and the "gut repair" claims beyond that are shaky.

Mechanisms, studies and evidence grades for each claim above.

Fuels the gut lining

Glutamine is the most abundant free amino acid in blood and muscle, and is classed as conditionally essential: the body makes enough under normal conditions, but demand can exceed supply during severe illness, injury, or intense training. Its signature use is as a primary fuel for enterocytes (the cells lining the small intestine) and for rapidly dividing immune cells, which is the basis for its place in gut-repair protocols. It's also a nitrogen carrier between tissues and a precursor to glutamate, and therefore to glutathione. (Strong — physiology)

Calms IBS after a gut infection

The strongest human result is in a specific subgroup: diarrhea-predominant IBS that began after an enteric infection, in patients with measurably increased intestinal permeability. In a randomized placebo-controlled trial of 106 completers, glutamine 5 g three times daily for 8 weeks achieved the primary endpoint (≥50-point drop in IBS severity) in 79.6% versus 5.8% on placebo. It also reduced stool frequency, improved stool form, and normalized the lactulose/mannitol permeability ratio, with side effects no different from placebo.¹

A 14-fold difference with a placebo response of only 6% is unusually large for IBS, a condition famous for high placebo response; the authors themselves call for larger trials. It is also a single-centre result in a narrowly selected group. (Moderate — one striking RCT, narrow population)

Tightens a leaky gut, but only at high doses

For "leaky gut" more broadly, the pooled evidence is weaker than the marketing. A 2024 meta-analysis of clinical trials in adults found that oral glutamine had no significant effect on intestinal permeability overall; only a subgroup receiving more than 30 g/day showed a reduction.² That dose is several times what most supplement protocols use. (Early — null overall, dose-dependent subgroup signal)

Fewer sickle-cell pain crises

Sickle red cells are under heavy oxidative stress, and glutamine is a precursor to NAD and glutathione within them. In a phase 3 trial of 230 children and adults with sickle cell anemia, oral L-glutamine for 48 weeks reduced the median number of pain crises (3 vs 4) and hospitalizations (2 vs 3) compared with placebo, on top of hydroxyurea in two-thirds of patients.³ This trial underpinned FDA approval. It was funded by Emmaus Medical, the company that markets the drug. (Moderate — phase 3 RCT, sponsor-funded)

Where it doesn't work

• Athletes. A meta-analysis of 47 studies (25 pooled) found glutamine had no effect on athletes' immune function, aerobic performance, or body composition, beyond a small weight reduction.⁴ (Strong for no performance effect)
• Critical illness. The logic that sick people become glutamine-depleted led to high-dose supplementation in intensive care. In the REDOXS trial of critically ill patients with multiorgan failure, early glutamine did not improve outcomes, and in-hospital and 6-month mortality were significantly higher with it.⁵ (Strong — a large RCT showing harm in this setting)
• Cancer. Many tumors are "glutamine-addicted", using it as a second fuel alongside glucose — a central point in the Seyfried framework discussed in Cancer as Metabolic Disease. Whether dietary or supplemental glutamine meaningfully feeds an existing tumor in people is not established, but it is a reason not to take high-dose glutamine without a specific indication if cancer is in the picture. (Inferred)

Intake & food sources

No RDA. A typical protein-containing diet supplies several grams a day, and the body synthesizes more, mainly in muscle. Supplemental dosing is goal-specific and usually short-term.

Top foods

• Beef
• Chicken and turkey
• Fish
• Eggs
• Yogurt and cheese

References